Amber Horhey

Doctor of Medicine,  CharitĂ© - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Hospital-Pharmacy-Insurance IT-Web-Mobile Technology Pharma-CRO-Device Admin and Customer Support Grant Submission

Areas Of Interest

beta-1 Adrenergic Blocking Agents Nuclear Complex, Septal DXA Scan Sequestration, Bronchopulmonary Head, Optic Nerve Replication Protein C Ethinyl Estradiol 3 Cyclopentyl Ether Astrocytoma, Childhood Cerebral Liver Abscess Semantic Network Human T Cell Leukemia Viruses Osseo-Anchored Prosthesis Fruit Flies, Mexican College Drinking DGK beta Opioid Epidemic Adulteration, Food Availability, Biological Nutritional Theospan Chimerin, alpha-1 Philately Interobserver Variabilities Bandages, Hydrogel

Professional Narrative

Dr. Amber Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Mayo Clinic 1993
Director Medicine, Harvard Med 2014

Education

Director Medicine, Harvard Medical School 1997
Doctor of medicine, Weill Medical College 2002

Referees


Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :